INVIZIUS

invizius-logo

Invizius is developing treatments to help hemodialysis patients live longer, feel better, and suffer fewer cardiovascular complications.

#SimilarOrganizations #People #Financial #Website #More

INVIZIUS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2018-01-01

Address:
Edinburgh, Edinburgh, City Of, United Kingdom

Country:
United Kingdom

Website Url:
http://www.invizius.com

Total Employee:
1+

Status:
Active

Total Funding:
10.15 M GBP

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Content Delivery Network Nginx Microsoft Exchange Online Office 365 Mail


Similar Organizations

aulos-bioscience-logo

Aulos Bioscience

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

cequr-logo

CeQur

CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.

xrapid-logo

xRapid

xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.

Current Employees Featured

andy-herbert_image

Andy Herbert
Andy Herbert CTO & Co-Founder @ Invizius
CTO & Co-Founder
2018-04-01

richard-boyd_image

Richard Boyd
Richard Boyd CEO @ Invizius
CEO
2018-04-01

magnus-nicolson_image

Magnus Nicolson
Magnus Nicolson Chairman @ Invizius
Chairman

not_available_image

Joe Conner
Joe Conner Principal Scientist @ Invizius
Principal Scientist
2019-11-01

Founder


andy-herbert_image

Andy Herbert

Investors List

biomedical-catalyst-fund_image

Biomedical Catalyst Fund

Biomedical Catalyst Fund investment in Grant - Invizius

jonathan-milner_image

Jonathan Milner

Jonathan Milner investment in Series A - Invizius

scottish-enterprise_image

Scottish Enterprise

Scottish Enterprise investment in Series A - Invizius

mercia-fund-management_image

Mercia Fund Managers

Mercia Fund Managers investment in Series A - Invizius

old-college-capital_image

Old College Capital

Old College Capital investment in Series A - Invizius

solvay-ventures_image

Solvay Ventures

Solvay Ventures investment in Series A - Invizius

downing-ventures_image

Downing Ventures

Downing Ventures investment in Series A - Invizius

calculus-capital_image

Calculus Capital

Calculus Capital investment in Series A - Invizius

old-college-capital_image

Old College Capital

Old College Capital investment in Series A - Invizius

scottish-investment-bank_image

Scottish Investment Bank

Scottish Investment Bank investment in Series A - Invizius

Official Site Inspections

http://www.invizius.com

  • Host name: 185.60.251.251
  • IP address: 185.60.251.251
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Invizius"

About Us - Invizius - second generation complement therapeutics โ€ฆ

Invizius spun out of world-leading research at the University of Edinburgh in 2018 Inspiration > Our team combines world-leading scientists, with senior executives from life science and โ€ฆSee details»

Invizius - LinkedIn

Invizius | 1,028 followers on LinkedIn. Fighting Inflammation at its Source | Invizius is a spin-out based on world-class Complement research carried out at the University of Edinburgh, Scotland.See details»

Invizius - Crunchbase Company Profile & Funding

Invizius offers extra-corporeal treatments for patients that includes dialysis, cardiopulmonary bypass, and ECMO involve the circulation of the patient's blood supply through a machine. โ€ฆSee details»

Invizius - Products, Competitors, Financials, Employees, โ€ฆ

Biotech raises further funds for โ€˜dialysis breakthroughโ€™ treatment. Sep 24, 2024. Invizius โ€“ the Edinburgh-based biotech company developing breakthrough treatments for patients on โ€ฆSee details»

Invizius 2025 Company Profile: Valuation, Funding & Investors

Invizius General Information Description. Operator of a biotech company intended to develop treatments to suppress unwanted innate immune responses. The company's product is an anti โ€ฆSee details»

Invizius Company Profile - Office Locations, Competitors ... - Craft

Invizius has 5 employees across 2 locations and $7.37 m in total funding,. See insights on Invizius including office locations, competitors, revenue, financials, executives, subsidiaries and more โ€ฆSee details»

INVIZIUS LIMITED Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for INVIZIUS LIMITED of EDINBURGH. Get the latest business insights from Dun & Bradstreet.See details»

Invizius - Overview, News & Similar companies | ZoomInfo.com

Invizius Treats First Patients in First-In-Human Phase 1 Clinical Study of Lead Dialysis Product H-Guard® First patients treated with H-Guard® at the National Institute for Health and Care โ€ฆSee details»

About Invizius - PharmiWeb.jobs

Feb 7, 2024 Inviziusโ€™ proprietary approach was born out of over ten years of research by Dr Andy Herbert into how pathogenic microbes evade the human complement system. Invizius is โ€ฆSee details»

About - Invizius - second generation complement therapeutics for ...

Invizius is the trading name of Invizius Limited. Invizius Limited is a limited company registered in Scotland, UK, with registration number SC586903. Invizius Limited's registered office is at โ€ฆSee details»

Invizius - F6S

Invizius is a spin-out based on world-class research carried out at the University of Edinburgh, Scotland, developing solutions to improve the treatment and prognosis for dialysis patients. โ€ฆSee details»

Invizius - Contacts, Employees, Board Members, Advisors & Alumni

Invizius provides dialysis treatments and other extra-corporeal treatments for patients.See details»

Invizius - MBM Commercial

Invizius spun-out of the University of Edinburgh in 2018 following research by the current CTO and co-founder Dr Andy Herbert. Over 3 million people in the UK live with chronic kidney โ€ฆSee details»

Home - Invizius - second generation complement therapeutics for ...

Invizius is a clinical stage biotech developing second generation complement therapies to treat inflammatory, fibrotic and autoimmune disorders Our Pipeline > Our proprietary technology โ€ฆSee details»

Invizius - CipherBio

Explore Invizius's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

News & Events - Invizius - second generation complement โ€ฆ

Read the Invizius's latest announcements here: News & Events - Invizius - second generation complement therapeutics for autoimmune and inflammatory disorders About UsSee details»

Invizius - Funding, Financials, Valuation & Investors - Crunchbase

Invizius provides dialysis treatments and other extra-corporeal treatments for patients. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. ... How much โ€ฆSee details»

Invizius Company Information - Funding, Investors, and More

The company Invizius has raised a total of $1.3m in funding over 1 rounds. Key Insights: Series A: $1.3m; 2024. Invizius Series A Round, September 2024 $1.3m. Similar startup. Track over โ€ฆSee details»

Meso-Guardโ„ข for Peritoneal Dialysis - Invizius - second generation ...

At Invizius we are developing products to treat diseases driven by excessive activation of the patient's complement system. Our first product, H-Guard® Priming Solution, is initially โ€ฆSee details»

Our complement therapy platform is inspired by the ... - Invizius

Inviziusโ€™s technical co-founders researched one of its key mechanisms for hiding from the complement (or innate immune) system โ€“ the pneumococcal surface protein C (PspCN) โ€“ a โ€ฆSee details»

linkstock.net © 2022. All rights reserved